Wharton, S., Blevins, T., Connery, L., Rosenstock, J., Raha, S., Liu, R., Ma, X., Mather, K.J., Haupt, A., Robins, D., Pratt, E., Kazda, C
My protocol during this period: Retatrutide: 2mg weekly subcutaneous injection (ramped to 4mg by week 10) GHK-Cu: 1mg daily subcutaneous, rotated injection sites Cycle length: 12 weeks on, 4 weeks off Training: 4 days resistance training per week, 8,000 to 10,000 steps daily Protein intake: 130g daily minimum I sourced both from Red Fox Peptides
Its also a good option for sensitive skin types
OVERALL CONCLUSIONS 5-Amino-1MQ enables precise interrogation of NNMTs role at the crossroads of NAD metabolism, one-carbon biochemistry, and adipocyte energetics
[3] What sets retatrutide apart from these medications is that its a GIPGLP-1GCG receptor agonist, sometimes referred to as triple G or a triple agonist